The discovery of proto-oncogenes was a paradigm shift in cancer biology. It revealed that cancer could be triggered by mutations in normal cellular genes, thereby highlighting the genetic basis of cancer. This understanding paved the way for the development of targeted cancer therapies that aim to specifically inhibit the function of these oncogenes.
